Effect of NT-proBNP Guided Treatment of Chronic Heart Failure

This study has been completed.

Sponsor:

Collaborator:

The Interuniversity Cardiology Institute of the Netherlands

Information provided by:

Netherlands Heart Foundation

ClinicalTrials.gov Identifier:

NCT00149422

First received: September 6, 2005

Last updated: February 8, 2010

Last verified: August 2008

History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	April 2009
Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)

No publications provided by Netherlands Heart Foundation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Eurlings LW, van Pol PE, Kok WE, van Wijk S, Lodewijks-van der Bolt C, Balk AH, Lok DJ, Crijns HJ, van Kraaij DJ, de Jonge N, Meeder JG, Prins M, Pinto YM. Management of chronic heart failure guided by individual N-terminal pro-B-type natriuretic peptide targets: results of the PRIMA (Can PRo-brain-natriuretic peptide guided therapy of chronic heart failure IMprove heart fAilure morbidity and mortality?) study. J Am Coll Cardiol. 2010 Dec 14;56(25):2090-100.

To Top